ANAVEX LIFE SCIENCES

Lobbying client · New York · filed 2025 to 2026

Biopharma innovator

$240,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (64790), not by name.

Firms hired 1

FORBES-TATE $240,000 6 filings

Reported by year 2 years

2026 $0 1 filing
2025 $240,000 5 filings

Issues lobbied 1

Health Issues 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 4
SENATE 4

Recent filings 7 total

1TY

FORBES-TATE

1st Quarter (Jan 1 - Mar 31) 2026 · posted May 13, 2026

View → Q1

FORBES-TATE Amended

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $40,000 income · posted Apr 17, 2026

View → Q4

FORBES-TATE

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 18, 2026

View → Q3

FORBES-TATE

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000 income · posted Oct 19, 2025

View → Q2

FORBES-TATE

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $60,000 income · posted Jul 18, 2025

View → Q1

FORBES-TATE

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $60,000 income · posted Apr 18, 2025

View → RR

FORBES-TATE

1st Quarter (Jan 1 - Mar 31) 2025 · posted Mar 11, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.